Article
Sex-based mutational landscape confers sensitivity to checkpoint blockade immunotherapy in cutaneous melanoma
2019-12-08
Abstract excerpt
Anti-programmed cell death protein 1 (PD-1) therapy provided superior benefits in skin cutaneous melanoma (SKCM), but only a minority of patients responded. As SKCM had sex-based immunological differences, we sought to explore the potential interactions between sex and clinical responses to anti-PD-1 therapy in SKCM. We found that sex had significant effects on anti-PD-1 therapy. Tumor mutation burden (TMB) and ne...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bd653f36-b755-5b89-a852-bea5b3cc82a8
- DOI
- 10.1101/868950
